Vincenzo Trischitta

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Endothelial Cells

Top Venues

Acta diabetologica

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica 61 (8) (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica 61 (8) (2024)
Claudia Menzaghi, Antonella Marucci, Mario Mastroianno, Giulio Di Ciaccia, Maria Pia Armillotta, Cornelia Prehn, Lucia Salvemini, Davide Mangiacotti, Jerzy Adamski, Andrea Fontana, Salvatore De Cosmo, Olga Lamacchia, Massimiliano Copetti, Vincenzo Trischitta
Inflammation and prediction of death in type 2 diabetes. Evidence of an intertwined link with tryptophan metabolism. The Journal of clinical endocrinology and metabolism (2024)
Alessandra Antonucci, Claudia Menzaghi, Alessandro Roberto Dodesini, Mascia Albizzi, Angelo Acquafredda, Grazia Fini, Vincenzo Trischitta, Rosa Di Paola
Rare forms of monogenic diabetes in non-European individuals. First reports of CEL and RFX6 mutations from the Indian subcontinent. Acta diabetologica (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica 61 (8) (2024)
Vincenzo Trischitta, Alessandra Antonucci, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica 61 (8) (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica (2024)
Vincenzo Trischitta, Claudia Menzaghi, Massimiliano Copetti
Unveiling Novel Markers and Modeling Clinical Prediction of Treatment Effects Are Equally Important for Implementing Precision Therapeutics. Diabetes 72 (8) (2023)
Massimiliano Copetti, Marco Giorgio Baroni, Raffaella Buzzetti, Maria Gisella Cavallo, Efiso Cossu, Paola D'Angelo, Salvatore De Cosmo, Frida Leonetti, Susanna Morano, Lelio Morviducci, Nicola Napoli, Sabrina Prudente, Giuseppe Pugliese, Antonio Fernando Savino, Vincenzo Trischitta
Validation in type 2 diabetes of a metabolomic signature of all-cause mortality. Diabetes/metabolism research and reviews (2023)
Rosa Di Paola, Antonella Marucci, Davide Mangiacotti, Alessandra Antonucci, Andrea Fontana, Xuan Wang, Lu Qi, Claudia Menzaghi, Vincenzo Trischitta
Leveraging Genetics to Address the Role of GALNT2 on Atherogenic Dyslipidemia. Advanced biology (2023)
Rosa Di Paola, Antonella Marucci, Vincenzo Trischitta
The Need to Increase Clinical Skills and Change the Genetic Testing Strategy for Monogenic Diabetes. Diabetes 71 (3) (2022)
Maria Giovanna Scarale, Mario Mastroianno, Cornelia Prehn, Massimiliano Copetti, Lucia Salvemini, Jerzy Adamski, Salvatore De Cosmo, Vincenzo Trischitta, Claudia Menzaghi
Circulating Metabolites Associate With and Improve the Prediction of All-Cause Mortality in Type 2 Diabetes. Diabetes 71 (6) (2022)
Rosa Di Paola, Alessandra Antonucci, Antonella Marucci, Vincenzo Trischitta
On the emerging role of GALNT2 on intermediate metabolism and adipogenesis. Acta diabetologica 59 (9) (2022)
Maria Giovanna Scarale, Alessandra Antonucci, Marina Cardellini, Massimiliano Copetti, Lucia Salvemini, Rossella Menghini, Tommaso Mazza, Viviana Casagrande, Gianluigi Ferrazza, Olga Lamacchia, Salvatore De Cosmo, Rosa Di Paola, Massimo Federici, Vincenzo Trischitta, Claudia Menzaghi
A Serum Resistin and Multicytokine Inflammatory Pathway Is Linked With and Helps Predict All-cause Death in Diabetes. The Journal of clinical endocrinology and metabolism 106 (11) (2021)
Maria Giovanna Scarale, Massimiliano Copetti, Monia Garofolo, Andrea Fontana, Lucia Salvemini, Salvatore De Cosmo, Olga Lamacchia, Giuseppe Penno, Vincenzo Trischitta, Claudia Menzaghi
The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes care 43 (5) (2020)
Caterina Pipino, Hetal S Shah, Sabrina Prudente, Natalia Di Pietro, Lixia Zeng, Kyoungmin Park, Vincenzo Trischitta, Subramanian Pennathur, Assunta Pandolfi, Alessandro Doria
Association of the 1q25 Diabetes-Specific Coronary Heart Disease Locus With Alterations of the γ-Glutamyl Cycle and Increased Methylglyoxal Levels in Endothelial Cells. Diabetes 69 (10) (2020)
Mario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, Petra A Lenzini, Hannah Campbell, Allison A Motsinger-Reif, He Gao, Laura Lovato, Sabrina Prudente, Assunta Pandolfi, Marcus G Pezzolesi, Ronald J Sigal, Guillaume Paré, Santica M Marcovina, Daniel M Rotroff, Elisabetta Patorno, Luana Mercuri, Vincenzo Trischitta, Emily Y Chew, Peter Kraft, John B Buse, Michael J Wagner, Sharon Cresci, Ulagamadesan Venkatesan, Henry N Ginsberg, Josyf C Mychaleckyj, Alessandro Doria
PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid. Diabetes 69 (4) (2020)
Vincenzo Trischitta, Massimiliano Copetti
Moving Toward the Implementation of Precision Medicine Needs Highly Discriminatory, Validated, Inexpensive, and Easy-to-Use Prediction Models. Diabetes care 43 (4) (2020)
Claudia Menzaghi, Vincenzo Trischitta
The Adiponectin Paradox for All-Cause and Cardiovascular Mortality. Diabetes 67 (1) (2018)
Vincenzo Trischitta, Sabrina Prudente
Some Doubts About the Mantra on the Deleterious Cardiovascular Effects of Sulfonylureas. Diabetes 66 (8) (2018)
Serena Pezzilli, Ornella Ludovico, Tommaso Biagini, Luana Mercuri, Federica Alberico, Eleonora Lauricella, Hamza Dallali, Daniele Capocefalo, Massimo Carella, Elide Miccinilli, Pamela Piscitelli, Maria Giovanna Scarale, Tommaso Mazza, Vincenzo Trischitta, Sabrina Prudente
Insights From Molecular Characterization of Adult Patients of Families With Multigenerational Diabetes. Diabetes 67 (1) (2017)